FDA Inspection 1041616 — Sciarra Laboratories, Inc.
The FDA completed an inspection of Sciarra Laboratories, Inc. on February 14, 2018 in Hicksville, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 14, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hicksville, NY (United States)